Your daily Selection of IRIN Africa PlusNews reports, 1/11/2007

January 11, 2007

U N I T E D N A T I O N S

Office for the Coordination of Humanitarian Affairs

Integrated Regional Information Network (IRIN) -

[These reports do not necessarily reflect the views of the United Nations]

CONTENT:

1 - ZIMBABWE: Scepticism over govt plan to treble ARV beneficiaries

BULAWAYO, 11 January (PLUSNEWS) - The Zimbabwean government has announced its

intention to treble the number of people on its free antiretroviral (ARV)

programme in 2007, but experts are sceptical about the health sector's capacity

to achieve this goal.

Continuing hyperinflation, now hovering around 1,200 percent annually, and a

scarcity of foreign currency have crippled healthcare provision, creating

shortages of drugs, medical equipment and even personnel, who have migrated in

search of better salaries and living conditions.

Owen Mugurungi, National Coordinator of the government's HIV/AIDS and

Tuberculosis programme, this week told the media that government had pulled

together resources that would be channelled into improving the lives of people

living with the virus and increase access to the life-prolonging drugs.

" We hope that by end of 2007 about 160,000 people would have been enrolled under

the ARV rollout programme, and we are working very hard to ensure that this

happens, " he said. Only 50,000 of an estimated 500,000 Zimbabweans in need of

ARVs are receiving the drugs from state institutions.

AIDS activists were quick to question Mugurungi's targets, describing them as

" empty and just too ambitious " .

Dumisani Nkomo, deputy chairperson of the Zimbabwe National Network for People

Living with HIV/AIDS, said he doubted the government's ability to treble the

number of those accessing treatment.

" It is a welcome development to hear government make such a pledge, but it would

appear just too ambitious to me. What they need to do is to go an extra mile,

way beyond simple pledges and promises, and harness resources that would promote

free or affordable distribution of ARVs.

" There are hundreds of thousands of infected people who die prematurely due to

lack of access to drugs, and it is high time our government manoeuvred from its

cocoon and faced reality; we need treatment as soon as possible, " said the

activist, who has lived with HIV for more than a decade.

A month's course of antiretroviral medication, which cost anywhere from US$200

to $400 (according to the official rate) on the parallel market in 2006, shot up

by another US$100 in January 2007.

According to official statistics, the southern African country has one of the

highest HIV prevalence rates in the world, with 18 percent of its 11.5 million

people infected. Statistics show that about 3,500 people succumb to the disease

every week, and health experts have attributed the large number of deaths to

lack of treatment, which is extremely difficult to obtain in rural areas.

Anita Mhlanga, 25, an activist from rural Madlambuzi, a village in southern

Zimbabwe, is living with the virus. She said the government has done little to

improve the lives of those infected, especially in the countryside.

" At clinics they tell us there will be treatment programmes soon; they started

saying so a long time ago, and now I am afraid I will die even before the

programme starts because I can now feel I am terribly sick and weak. My child

passed away two weeks ago and I know I am next. My boyfriend is also not feeling

well ... if we had the ARVs that we hear people talk of, I think we would be

better off and live longer. Government should work hard to make treatment

accessible to all communities, " said Mhlanga.

Zimbabwe started rolling out drugs at its Opportunistic Infection Clinics four

years ago, but the programme has largely been confined to urban areas. The

second city of Bulawayo has four of these clinics, which cater to 5,000

patients.

According to the authorities, most of the drugs the government wishes to roll

out will be manufactured locally by the country's main supplier, Varichem, which

requires at least US$1 million in scarce foreign exchange every month for

importing raw materials to produce the life-prolonging medication.

nn/jk/he/oa

[ENDS]

This is non-reply e-mail. Please do not hesitate to contact us at

Mail@....

Principal donors: IRIN is generously supported by Australia, Canada, Denmark,

ECHO, Japan, Netherlands, Norway, Sweden, Switzerland, the United Kingdom and

the United States of America. For more information, go to:

http://www.IRINnews.org/donors

[This item comes to you via IRIN, a UN humanitarian news and information

service, but may not necessarily reflect the views of the United Nations or its

agencies. All IRIN material may be reposted or reprinted free-of-charge; refer

to the copyright page (Http://www.irinnews.org/copyright ) for conditions of

use. IRIN is a project of the UN Office for the Coordination of Humanitarian

Affairs.]

PLUSNEWS

Tel: +27 11 895-1900

Fax: +27 11 784-6759

Email: Mail@...

To make changes to or cancel your subscription visit:

http://www.irinnews.org/subscriptions

Subscriber: AIDS treatments

January 11, 2007